SRF Limited commissions new plant

SRF Limited had earlier approved for a project to create Pharma Intermediates Plant for undertaking precursor processes for production of Pharma products at Dahej.

The project has been commissioned and capitalized on 12th April, 2023 at an aggregate cost of Rs. 223 Crores (approx.).

Shares of SRF Limited was last trading in BSE at Rs. 2424.75 as compared to the previous close of Rs. 2398.25. The total number of shares traded during the day was 6449 in over 1430 trades.

The stock hit an intraday high of Rs. 2429.00 and intraday low of 2398.15. The net turnover during the day was Rs. 15593022.00.

Source : Equity Bulls

Keywords

SRF INE647A01010 ExpansionProject Commissioned Dahej